These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Dofferhoff AS; Vellenga E; Limburg PC; van Zanten A; Mulder PO; Weits J Neth J Med; 1991 Aug; 39(1-2):45-62. PubMed ID: 1961351 [TBL] [Abstract][Full Text] [Related]
3. Gram-negative endotoxins and staphylococcal toxic shock syndrome. de Azavedo JC; Hartigan PJ; de Saxe M; Arbuthnott JP Prog Clin Biol Res; 1985; 189():419-32. PubMed ID: 4048216 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of septic shock and implications for therapy. Barron RL Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370 [TBL] [Abstract][Full Text] [Related]
5. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Opal SM Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016 [TBL] [Abstract][Full Text] [Related]
6. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746 [TBL] [Abstract][Full Text] [Related]
7. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Villar J; Ribeiro SP; Mullen JB; Kuliszewski M; Post M; Slutsky AS Crit Care Med; 1994 Jun; 22(6):914-21. PubMed ID: 8205824 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory cytokine levels in patients with septic shock. Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313 [TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor in septic shock. Koltai M; Hosford D; Braquet PG New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397 [TBL] [Abstract][Full Text] [Related]
11. Role of macrophage scavenger receptor in endotoxin shock. Kobayashi Y; Miyaji C; Watanabe H; Umezu H; Hasegawa G; Abo T; Arakawa M; Kamata N; Suzuki H; Kodama T; Naito M J Pathol; 2000 Oct; 192(2):263-72. PubMed ID: 11004705 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. Dinarello CA; Okusawa S; Gelfand JA Prog Clin Biol Res; 1989; 286():243-63. PubMed ID: 2494673 [TBL] [Abstract][Full Text] [Related]
13. Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats. Nishiyama T Eur J Pharmacol; 2009 Jul; 614(1-3):122-7. PubMed ID: 19318092 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686 [TBL] [Abstract][Full Text] [Related]
15. Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of the interleukin-1 receptor. Norman JG; Sutton ET; Franz MS; Baker CH Shock; 1995 May; 3(5):369-75. PubMed ID: 7648339 [TBL] [Abstract][Full Text] [Related]
16. Antibiotics and endotoxic shock. McCabe WR Bull N Y Acad Med; 1975 Oct; 51(9):1084-95. PubMed ID: 1058731 [TBL] [Abstract][Full Text] [Related]
17. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430 [TBL] [Abstract][Full Text] [Related]